GSK plc (BCBA:GSK)

Argentina flag Argentina · Delayed Price · Currency is ARS
18,390
-120 (-0.65%)
Last updated: Dec 4, 2025, 1:51 PM BRT
92.57%
Market Cap 139.28T
Revenue (ttm) 59.26T
Net Income (ttm) 10.12T
Shares Out n/a
EPS (ttm) 2,447.74
PE Ratio 13.76
Forward PE 10.04
Dividend 476.22 (2.59%)
Ex-Dividend Date Nov 14, 2025
Volume n/a
Average Volume 280
Open 18,440
Previous Close 18,510
Day's Range 18,390 - 18,440
52-Week Range 9,110 - 18,880
Beta n/a
RSI 56.51
Earnings Date Feb 4, 2026

About GSK plc

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It a... [Read more]

Industry Pharmaceutical Preparations
Founded 1715
Employees 68,629
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol GSK
Full Company Profile

Financial Performance

In 2024, GSK plc's revenue was 31.38 billion, an increase of 3.46% compared to the previous year's 30.33 billion. Earnings were 2.58 billion, a decrease of -47.75%.

Financial numbers in GBP Financial Statements

News

There is no news available yet.